|
MDRO
|
Origin of responses
|
Total responses
|
Additional pre-emptive CP based on patient’s historya
|
CP only required if specific risk factors presentb
|
Additional pre-emptive CP but only if specific risk factors
|
None applicable
|
p-valuec
|
|---|
|
MRSA
|
EU
|
126
|
117 (92.9)
|
1 (0.8)
|
1 (0.8)
|
7 (5.6)
|
0.038
|
|
Non EU
|
38
|
30 (78.9)
|
1 (2.6)
|
2 (5.3)
|
5 (13.2)
|
|
GRE
|
EU
|
94
|
81 (86.2)
|
3 (3.2)
|
1 (1.1)
|
9 (9.6)
|
0.265
|
|
Non EU
|
30
|
24 (80.00)
|
2 (6.7)
|
2 (6.7)
|
2 (6.7)
|
|
ESBL E. coli
|
EU
|
91
|
74 (81.3)
|
8 (8.8)
|
4 (4.7)
|
5 (4.7)
|
0.812
|
|
Non EU
|
26
|
22 (84.6)
|
1 (3.8)
|
2 (7.7)
|
1 (3.8)
|
|
ESBL non-E. coli
|
EU
|
101
|
86 (85.1)
|
5 (5.0)
|
3 (3.0)
|
7 (6.9)
|
0.131
|
|
Non EU
|
23
|
18 (78.3)
|
3 (13.0)
|
2 (8.7)
|
0 (0.0)
|
|
Carbapenem resistant E. coli
|
EU
|
120
|
103 (85.8)
|
4 (3.3)
|
4 (3.3)
|
9 (7.5)
|
0.465
|
|
Non EU
|
36
|
33 (91.7)
|
0 (0.0)
|
2 (5.6)
|
1 (2.8)
|
|
Carbapenem resistant Enterobacteriaceae (non-E. coli)
|
EU
|
126
|
111 (88.1)
|
2 (1.6)
|
4 (3.2)
|
9 (7.1)
|
0.560
|
|
Non EU
|
37
|
33 (89.2)
|
1 (2.7)
|
2 (5.4)
|
1 (2.7)
|
|
MDR P. aeruginosa
|
EU
|
112
|
96 (85.7)
|
3 (2.7)
|
4 (3.6)
|
9 (8.0)
|
0.178
|
|
Non EU
|
35
|
31 (88.6)
|
1 (2.9)
|
3 (8.6)
|
0 (0.0)
|
|
MDR A. baumannii
|
EU
|
120
|
107 (89.2)
|
1 (0.8)
|
5 (4.2)
|
7 (5.8)
|
0.758
|
|
Non EU
|
33
|
31 (91.2)
|
0 (0.0)
|
2 (5.9)
|
1 (2.9)
|
- aFormerly positive for respective MDRO or presumptive infection/colonization with respective MDRO
- bCP only when certain risk factors present e.g. incontinence, diarrhoea, draining wounds
- cA two-sided p-value of < 0.05 was considered statistically significant
